There are 2867 resources available
Is germline testing needed and does it impact treatment decisions?
Presenter: Elena Castro Marcos
Session: Using molecular data that impacts clinical practice
Resources:
Slides
Webcast
Advocating for patients with ultra-rare cancer
Presenter: Hugh Leonard
Session: Ultra-rare sarcoma: Navigating an endless sea
Resources:
Slides
Webcast
Invited Discussant 277O and 278O
Presenter: Giuseppe Minniti
Session: Proffered Paper session: CNS tumours
Resources:
Slides
Webcast
518O - Overall survival results from ARIEL4: A phase III study assessing rucaparib vs chemotherapy in patients with advanced, relapsed ovarian carcinoma and a deleterious BRCA1/2 mutation
Presenter: Amit Oza
Session: Proffered Paper session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
ICI landscape in solid tumours: what are the scores, are there differences and why?
Presenter: Luís Castelo-Branco
Session: 5-year impact of new registered indications on the ESMO-MCBS
Resources:
Slides
Webcast
The impact of COVID-19 on advocacy networks
Presenter: Lydia Makaroff
Session: The impact of COVID-19 on patients with cancer: Lessons learnt and pathway for the future
Resources:
Slides
Webcast
Clinical development of next generation DDR agents for molecularly-selected tumours
Presenter: Timothy Yap
Session: Exploiting synthetic lethality: The next generation
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Updates in the standard of care of metastatic breast cancer
Resources:
Webcast
Immune signatures in the tumour microenvironment
Presenter: Kevin Litchfield
Session: How the tumour microenvironment affects outcome and therapy response?
Resources:
Slides
Webcast
Will circulating tumour DNA have a role in treatment decisions?
Presenter: Florian Scherer
Session: How diagnostic tools impact therapy of haematological malignancies
Resources:
Slides
Webcast